About PHA Staff

This author has not yet filled in any details.
So far PHA Staff has created 264 blog entries.

Rebekah Calverley Lives an Amazing, Beautiful, Fearless Life with Pulmonary Hypertension

2018-04-20T19:57:22+00:00 April 26th, 2018|

Born in Auckland, New Zealand, Rebekah was sick a lot as a toddler with colds and even pneumonia.  That didn’t stop her from being active like any other child as her parents searched for answers for her continued illnesses. When she was two and a half, she was jumping on a trampoline, struggling to

PHA’s Pathlight Membership Magazine to Highlight PHCC Clinicians

2018-04-25T20:19:04+00:00 April 25th, 2018|

The upcoming issue of Pathlight, a complementary quarterly magazine for Pulmonary Hypertension Association (PHA) members, introduces a new feature called, PHour Questions. The segment  will introduce clinicians from Pulmonary Hypertension Care Center (PHCCs), including Pulmonary Hypertension Association Registry (PHAR)-participating centers. The new feature asks four insightful questions about how these experts are advancing, PH

Global Community Joins Hearts to Advocate for People Living with a Commonly Misdiagnosed and Deadly Lung Disease

2018-04-20T16:08:20+00:00 April 20th, 2018|

SILVER SPRING, MD (April 13, 2018) – Organizations around the world will join forces on May 5 to raise awareness for pulmonary hypertension (PH).  PH is a complex, life-threatening, too-often misdiagnosed progressive illness that affects 25 million adults and children worldwide. On World PH Day, dozens of sister organizations will raise awareness for the need

Ask the Expert: Managing Seasonal Allergies in Patients With Pulmonary Hypertension (PH)

2018-04-20T14:04:36+00:00 April 20th, 2018|

By Nathan Verlinden, Cardiology Clinical Pharmacy Specialist, Allegheny General Hospital, Pittsburgh Nathan Verlinden received his PharmD from Drake University in Des Moines, Iowa, in 2013. He then completed a post-graduate year 1 (PGY-1) pharmacy practice residency at the University of Toledo Medical Center in Toledo, Ohio, followed by a PGY-2 specialty residency in cardiology at

Nadine Al-Naamani, M.D., M.S., Aldrighetti Research Award for Young Investigators Grant Recipient, Shares Research Journey and Hope for the Future

2018-04-13T14:26:59+00:00 April 11th, 2018|

Nadine Al-Naamani, M.D., M.S., University of Pennsylvania, and Andrew Sweatt, M.D., Stanford University, were the research awardees of the 2017 Aldrighetti Research Award for Young Investigators and PHA/ATS Research Fellowship in Pulmonary Arterial Hypertension, respectively. In this two-part series, the 2017 PHA Research Program awardees detail their journey to PH, and their hopes for

Study Finds Inhaled Nitric Oxide May Benefit Patients with COPD and Pulmonary Hypertension

2018-04-11T15:26:35+00:00 April 11th, 2018|

by Phyllis Hanlon, Contributing Writer   The Centers for Disease Control and Prevention (CDC) reports that about 15.7 million people in the U.S. have been diagnosed with chronic obstructive pulmonary disease (COPD). The CDC noted in 2014 that this disease was the third leading cause of death in the U.S. Previous research has estimated that between

Early Diagnosis and Advanced Care Put Indianapolis Mom with Pulmonary Hypertension on Promising Path

2018-04-10T15:29:35+00:00 April 10th, 2018|

Indianapolis, Ind. (April 10, 2018) -- Donna Sparks combats a progressive life-threatening lung disease with courage, conviction and compassion -- for herself and others who share her fight. Diagnosed three years ago with pulmonary hypertension (PH), Donna is an active participant in myPHA, the Pulmonary Hypertension Association (PHA)’s online support community for individuals and

2017 PHA/ATS Research Fellowship in Pulmonary Arterial Hypertension Award Grantee Discusses Work and Research

2018-04-09T19:20:14+00:00 April 6th, 2018|

Andrew Sweatt, M.D., Stanford University, and Nadine Al-Naamani, M.D., M.S., University of Pennsylvania, are the research awardees of the 2017 PHA/ATS Research Fellowship in Pulmonary Arterial Hypertension and Aldrighetti Research Award for Young Investigators, respectively. In the first of a two-part series, Dr. Sweatt discusses his research journey, grant awarded study and involvement with the

Clinicians Explore Mindfulness as a Possible Benefit to Complement Pulmonary Hypertension Treatments

2018-04-06T14:21:26+00:00 April 6th, 2018|

Note: PHA cautions PH patients to check with their doctor before taking up yoga, meditation and other mindfulness practices. Pulmonary hypertension (PH) is a progressive disease that affects the heart and the lungs (Lai, Potoka, Champion, Mora & Gladwin, 2014). Patients with this disease are treated to help control the pulmonary pressures and prevent